| Literature DB >> 31794998 |
Stenio Medeiros Queiroz1, Ana Luiza Dias Leite De Andrade2, Patrícia Teixeira De Oliveira3, Paulo Raphael Leite Maia3, Ângelo Giuseppe Roncalli Da Costa Oliveira3, Roseana De Almeida Freitas2, Hébel Cavalcanti Galvão1.
Abstract
OBJECTIVE: The aim was to correlate radiomorphometric indices and biochemical analyses as an auxiliary method in bone evaluation in male and female patients with chronic kidney disease-mineral and bone disorder (CKD-MBD) and controls.Entities:
Year: 2019 PMID: 31794998 PMCID: PMC6890480 DOI: 10.1055/s-0039-1688738
Source DB: PubMed Journal: Eur J Dent
Fig. 1Measurements: Distance between the upper border of the MF-ABC; HMF; THM; MI; panoramic mandibular index. HMF, height of the mental foramen; MF-ABC, mental foramen to the upper border of the alveolar bone crest; MI, mental index, THM: Total height of the mandible.
Fig. 2Normal cortex—the endosteal margin of the cortex was even and sharp on both sides ( A and B ). C2: Mildly-to-moderately eroded cortex—The endosteal margin showed semilunar defects (lacunar resorption) or it appeared to form endosteal cortical residues ( C and D ). C3: severely eroded cortex—The cortical layer formed heavy endosteal cortical residues and it was clearly porous ( E and F ).
Fig. 3Classification of trabecular bone pattern. Dense homogeneous trabeculation: many trabeculae connected to each other and an impression of small/few marrow spaces ( A and B ). Heterogeneous trabeculation: when both dense and sparse trabeculation is found and when there are difficulties sorting the trabecular pattern under dense or space ( C and D ). Sparse trabeculation: fewer trabeculae, larger marrow spaces, and an impression of more radiolucency in the image ( E and F ). Specifically, for secondary hyperparathyroidism, the category sparse with ground-glass appearance ( G and H ).
Descriptive statistics and Mann–Whitney U test for radiomorphometric indices and laboratory parameters for patients with chronic kidney disease–mineral and bone disorder and control group according to gender
| Variables | Gender | Patients with CKD-MBD | Control group | ||
|---|---|---|---|---|---|
| Mean ± SD |
| Mean ± SD |
| ||
| Abbreviations: ABR, alveolar bone resorption; Ca × P, calcium × phosphorus product; Ca, calcium; CKD-MBD, chronic kidney disease-mineral and bone disorder; HMF, height at the mental foramen; MF-ABC, mental foramen-alveolar bone crest; MI, mental index; OHM, original height of the mandible; P, phosphorus; PMI, panoramic mandibular index; PTH, parathyroid hormone; SD, standard deviation; THM, total height of the mandible. | |||||
|
| |||||
| MI | Male | 1.86 ± 1.23 | 0.28 | 3.78 ± 0.54 | 0.11 |
| Female | 1.63 ± 1.22 | 3.61 ± 0.63 | |||
| HMF | Male | 8.89 ± 1.70 | 0.39 | 10.16 ± 1.30 | <0.01 |
| Female | 8.60 ± 1.53 | 9.24 ± 1.30 | |||
| THM | Male | 26.19 ± 2.61 | 0.01 a | 27.42 ± 2.50 | <0.01 |
| Female | 24.02 ± 3.39 | 24.91 ± 1.76 | |||
| PMI | Male | 0.21 ± 0.15 | 0.34 | 0.38 ± 0.07 | 0.30 |
| Female | 0.19 ± 0.14 | 0.40 ± 0.09 | |||
| OHM | Male | 25.77 ± 4.94 | 0.39 | 29.45 ± 3.77 | <0.01 |
| Female | 24.94 ± 4.42 | 26.79 ± 3.76 | |||
| ABR | Male | 0.20 ± 0.31 | 0.19 | 0.11 ± 0.97 | 0.29 |
| Female | 0.11 ± 0.09 | 0.12 ± 0.08 | |||
| MF-ABC | Male | 14.01 ± 3.12 | 0.04 a | 14.36 ± 2.17 | 0.02 |
| Female | 12.71 ± 2.43 | 13.12 ± 1.91 | |||
|
| |||||
| PTH | Male | 944.71 ± 278.58 | 0.13 | 15.61 ± 4.09 | 0.10 |
| Female | 1142.14 ± 483.52 | 18.88 ± 9.84 | |||
| Ca | Male | 9.13 ± 0.51 | 0.41 | 9.79 ± 0.50 | 0.34 |
| Female | 9.06 ± 0.98 | 9.88 ± 0.60 | |||
| P | Male | 5.42 ± 0.92 | 0.50 | 3.47 ± 0.51 | 0.69 |
| Female | 5.60 ± 1.11 | 3.43 ± 0.57 | |||
| Ca × P | Male | 49.11 ± 10.14 | 0.62 | 33.93 ± 5.41 | 0.81 |
| Female | 50.79 ± 11.78 | 33.96 ± 6.09 | |||
Descriptive statistics and Mann–Whitney U test for radiomorphometric indices and laboratory parameters for control group according to gender
| Variables | Gender | Mean ± SD |
|
|---|---|---|---|
| Abbreviations: ABR, alveolar bone reabsorption; Ca × P, calcium × phosphorus product; Ca, calcium; HMF, height at the mental foramen; MF-ABC, mental foramen-alveolar bone crest; MI, mental index; OHM, original height of the mandible; P, phosphorus; PMI, panoramic mandibular index; PTH, parathyroid hormone; SD, standard deviation; THM, total height of the mandible. | |||
|
| |||
| MI | Male | 3.78 ± 0.54 | 0.10 |
| Female | 3.61 ± 0.63 | ||
| HMF | Male | 10.16 ± 1.30 | < 0.01 a |
| Female | 9.24 ± 1.30 | ||
| THM | Male | 27.28 ± 2.51 | 0.01 a |
| Female | 24.81 ± 1.76 | ||
| PMI | Male | 0.38 ± 0.07 | 0.30 |
| Female | 0.40 ± 0.09 | ||
| OHM | Male | 29.45 ± 3.77 | < 0.01 a |
| Female | 26.79 ± 3.76 | ||
| ABR | Male | 0.11 ± 0.97 | 0.61 |
| Female | 0.12 ± 0.08 | ||
| MF-ABC | Male | 14.36 ± 2.17 | 0.02 a |
| Female | 13.12 ± 1.91 | ||
|
| |||
| PTH | Male | 15.61 ± 4.09 | 0.10 |
| Female | 18.88 ± 9.84 | ||
| Ca | Male | 9.79 ± 0.50 | 0.34 |
| Female | 9.88 ± 0.60 | ||
| P | Male | 3.47 ± 0.51 | 0.68 |
| Female | 3.43 ± 0.57 | ||
| Ca × P | Male | 33.93 ± 5.41 | 0.80 |
| Female | 33.96 ± 6.09 | ||
Frequency distribution and chi-squared test for the variables mandibular cortical index and bone trabecular pattern according to the control group and group of patients with chronic kidney disease-mineral and bone disorder
| Patients | Control |
| |
|---|---|---|---|
| Abbreviations: C1, normal cortex; C2, moderately eroded cortex; C3, severely eroded cortex; MCI, mandibular cortical index. | |||
| MCI | |||
| C1 |
16.67% (
|
87.12% (
| < 0.01 a |
| C2 |
37.88% (
|
12.88% (
| |
| C3 |
45.45% (
|
0.00% (
| |
| Trabecular bone pattern | |||
| Dense |
7.59% (
|
36.37% (
| < 0.01 a |
| Heterogeneous |
30.34% (
|
58.33% (
| |
| Sparse |
18.19% (
|
5.30% (
| |
| Sparse with ground-glass appearance |
43.94% (
|
0.00% (
| |